News (204)

European Healthcare Acquisition & Growth Company B.V. announces change in CEO position EQ
European Healthcare Acquisition & Growth B : Halfjaarlijkse financiële verslaggeving PU
CROMA-PHARMA GmbH cancelled the acquisition of European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
UCB : H1 surpassed expectations, Bimzelx’s US approval much-awaited in Q3 Alphavalue
Circles: Chinese manufacturer makes offer for Merck's pigments business DP
UCB : Exceeded 2022 expectations; promising prospects, despite muted 2023 guidance Alphavalue
European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH signed Business Combination Agreement EQ
CROMA-PHARMA GmbH agreed to acquire European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
UCB : Changes in UCB’s Board of Directors PU
European Healthcare Acquisition & Growth B : 2021 EHC Annual ReportK PU
Merck : Compensation Report 2021 PU
European Healthcare Acquisition & Growth Company B.V.: Former German healthcare leader of McKinsey & Company, Thomas Rudolph, takes office EQ
European Healthcare Acquisition & Growth Company B.V. announces bookbuilding for up to EUR 200 million private placement EQ
European Healthcare: Sponsor team with outstanding track record launches first-of-its-kind novel acquisition and growth vehicle in the European healthcare sector EQ
AiCuris Anti infective Cures : AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the Supervisory Board EQ
UCB : General Meeting of Shareholders 2021 PU
Transcript : MERCK Kommanditgesellschaft auf Aktien - Shareholder/Analyst Call
Merck : Sustainability Report 2020 PDF PU
UCB S : NV - Convening notice annual shareholders meeting AQ
Transcript : MERCK Kommanditgesellschaft auf Aktien, Q4 2020 Earnings Call, Mar 04, 2021
Merck : Corporate Governance Statement 2020 (Version March 2021) PU
Merck : agrees $1 billion deal with Debiopharm for head and neck cancer drug RE
Merck KGaA, Darmstadt, Germany :, Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant PR
UCB Full Year Report 2020: UCB - sustaining growth, now and into the future PR
BioNTech : Merck and BioNTech Extend Strategic Partnership through Accelerated Supply of Urgently Needed Lipids AQ
Transcript : MERCK Kommanditgesellschaft auf Aktien Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 04:30 AM
Merck : Acquires AmpTec to Bolster mRNA Potential DJ
Merck : MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics AQ
Merck : MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant AQ
Merck : Majority of generic drug ingredients produced in Asia - study RE
UCB : Changes in UCB's Board of Directors AQ
UCB : Changes in UCB's Board of Directors PU
Merck : Appoints New Executive Board Chair, CEO DJ
Transcript : MERCK Kommanditgesellschaft auf Aktien - Special Call
Merck : Agenda PU
Merck : says it has overcome production shortages in vaccine materials RE
Transcript : MERCK Kommanditgesellschaft auf Aktien - Analyst/Investor Day
Merck : Germany's Merck says it will focus on smaller takeovers RE
Second Quarter: Group Remains on Course in a Challenging Environment PU
Transcript : MERCK Kommanditgesellschaft auf Aktien, Q2 2020 Earnings Call, Aug 06, 2020
Merck : Leadership Change within Group Communications at Merck KGaA, Darmstadt, Germany PU
Second Quarter: Group Remains on Course in a Challenging Environment PU
Q2 20 Analyst call, August 06, 2020, 2:00pm CET PU
Merck : Changes in Merck KGaA, Darmstadt, Germany, Executive Board PU
Transcript : MERCK Kommanditgesellschaft auf Aktien - Shareholder/Analyst Call
1234NextSee all

Companies (1)

NOHO PARTNERS OYJ 186 M $
Logo NoHo Partners Oyj

NoHo Partners Oyj, formerly Restamax Oyj, is a Finland-based holding company engaged in the hospitality industry. The Company's business involves operation of restaurants and provision of labor hire services. In the Restaurant business segment, the Compan ...


Insiders

Stefan Oschmann
Stefan Oschmann

Dr. Stefan Oschmann is a Chairman at UCB SA, a Managing Partner at Oschmann Comfortbetten GmbH, a Chief Executive Officer at Millipore SpA, a Director & Vice President at European Federation of Pharmaceutical Industries & Assns, a Member at European Roundtable of Industrialists, a Member-Executive Committee at Verband der Chemischen Industrie eV, a Vice Chairman & Chairman-Executive Board at E. Merck KG and a Vice President at International Federation of Pharmaceutical Manufacturers. He is on the Board of Directors at Springer Nature AG & Co. KGaA, Verband Forschender Arzneimittelhersteller e.V., European Federation of Pharmaceutical Industries & Assns, Paul Ehrlich-Foundation and E. Merck KG. Dr. Oschmann was previously employed as a Chairman-Executive Board & CEO by Merck KGaA, a Managing Director by MSD Sharp & Dohme GmbH, a President-Europe, Middle East, Africa & Canada by Merck & Co., Inc., a Chief Executive Officer by Merck Serono SA, and a Member-Supervisory Board by Springer Nature Deutschland GmbH. He received his doctorate degree from Ludwig-Maximilians-Universität München.







Picture Jacobus M. Oschmann
Jacobus M. Oschmann

Jacobus M.
Oschmann
worked as a Principal at Hughes Aircraft Co. and Northrop Grumman Space & Mission Systems Corp.
He was also a Vice President & GM-Tactical Solutions at Ball Aerospace & Technologies Corp.
from 2012 to 2014.
He worked as a Principal at Saab Sensis Corp.
and Gemini Observatory.
Additionally, he served as the President of The International Society for Optical Engineering.
Oschmann received his undergraduate degree from the University of Rochester and his graduate degree and MBA from the University of Arizona.



Picture Michael Oschmann
Michael Oschmann

Michael Oschmann currently works at ad pepper media International NV, as Chairman-Supervisory Board from 2000, Müller Medien GmbH & Co. KG, as Co-Managing Director from 2000, Electronic Media Advertising International BV, as Managing Director, Telefonbuch Verlag Hans Müller GmbH & Co. KG, as Managing Director from 2010, competence media systems gmbh, as Co-Managing Director, Euro Serve Media GmbH, as Managing Director, Das Örtliche, as Director, Kramer Verlags GmbH & Co. KG, as Co-Managing Director, KELSTA Telefonbuchverlag GmbH, as Co-Managing Director, Prisma Medienbeteiligungsgesellschaft mbH, as Co-Managing Director from 2017, MC Verwaltungs GmbH, as Managing Director, MON.de GmbH, as Co-Managing Director, and anwalt.de services AG, as Member-Supervisory Board.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW